These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10614851)

  • 21. An appropriate defibrillation threshold obtained by the combined connection between two shock leads and ICD generator.
    Sato A; Chinushi M; Iijima K; Watanabe H; Izumi D; Furushima H; Sonoda K; Hasegawa K; Yagihara N; Aizawa Y
    Intern Med; 2011; 50(22):2815-8. PubMed ID: 22082895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations.
    Natale A; Sra J; Axtell K; Akhtar M; Newby K; Kent V; Geiger MJ; Brandon MJ; Kearney MM; Pacifico A
    Circulation; 1996 Jan; 93(1):91-8. PubMed ID: 8616948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
    Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm.
    Grimm W; Menz V; Hoffmann J; Maisch B
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):722-7. PubMed ID: 9584303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of ventricular fibrillation in relation to cardiac aetiology and shock success: A waveform analysis study in ICD-patients.
    Bonnes JL; Keuper W; Westra SW; Zegers ES; Oostendorp TF; Brouwer MA; Smeets JL
    Resuscitation; 2015 Jan; 86():95-9. PubMed ID: 25449343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Implantable cardioverter-defibrillator oversensing due to electric shock].
    Jurcević R; Angelkov L; Vukajlović D; Ristić V; Tomović M; Djukanović B
    Srp Arh Celok Lek; 2010; 138(3-4):236-9. PubMed ID: 20499508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator.
    Luo J; Pripp CM; Hertervig E; Kongstad O; Ljungström E; Olsson SB; Yuan S
    BMC Cardiovasc Disord; 2004 Jun; 4():8. PubMed ID: 15186504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure.
    Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y
    Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.
    Singer I; Adams L; Austin E
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1070-9. PubMed ID: 7685888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.
    Rüppel R; Schlüter CA; Boczor S; Meinertz T; Schlüter M; Kuck KH; Cappato R
    J Am Coll Cardiol; 1998 Nov; 32(6):1724-30. PubMed ID: 9822102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias.
    Ellenbogen KA; Wood MA; Stambler BS; Welch WJ; Damiano RJ
    Am J Cardiol; 1992 Oct; 70(11):1017-22. PubMed ID: 1414898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical aspects of automatic implantable cardioverter defibrillator (AICD) in patients with life-threatening ventricular tachyarrhythmias].
    Matsui Y; Shiiya N; Murashita T; Miyama M; Oba J; Gohda T; Sakuma M; Yasuda K; Tanabe T; Sakurai M
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):531-6. PubMed ID: 8515150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator.
    Grimm W; Flores BF; Marchlinski FE
    Am J Cardiol; 1993 Jun; 71(16):1415-8. PubMed ID: 8517386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
    Russo AM; Nayak H; Verdino R; Springman J; Gerstenfeld E; Hsia H; Marchlinski FE
    Pacing Clin Electrophysiol; 2003 Dec; 26(12):2289-95. PubMed ID: 14675014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate sensing of ventricular fibrillation after failed shocks in a transvenous cardioverter-defibrillator system.
    Ellis JR; Martin DT; Venditti FJ
    Circulation; 1994 Oct; 90(4):1820-5. PubMed ID: 7923667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.